Citation, DOI, disclosures and article data
At the time the article was created Kennedy Wong had no recorded disclosures.View Kennedy Wong's current disclosures
At the time the article was last revised Craig Hacking had no recorded disclosures.View Craig Hacking's current disclosures
Intercritical gout is the asymptomatic stage between attacks of acute gouty arthritis.
During the asymptomatic phase, the joints may be non-tender and without erythema or swelling. Patients can experience multiple gout attacks with asymptomatic periods of several months in between.
During the acute gouty arthritis phase, chemotactic factors are produced to recruit macrophages which remove monosodium urate crystals and facilitate apoptotic cell removal. This process helps produce anti-inflammatory cytokines and stops the inflammatory process. As a result, the cellular and chemokine activation are suppressed, and the acute phase is terminated 1.
Most radiological findings of gout are due to repeated inflammation and joint degeneration. No radiological features are specific for the initial presentation of acute gouty arthritis. Joint degenerative changes occur in the chronic stages of gout.
Treatment and prognosis
Treatment involves symptomatic relief for acute attacks of gout with non-steroidal anti-inflammatory drugs (NSAIDs), steroids, or colchicine.
Long-term management will involve urate-lowering medications such as xanthine oxidase inhibitors, uricosuric drugs, or uricase agents 2.
- 1. Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective - A review. J Adv Res. 2017;8(5):495-511. doi:10.1016/j.jare.2017.04.008
- 2. Liza Wilson, Joseph J. Saseen. Gouty Arthritis: A Review of Acute Management and Prevention. (2016) Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36 (8): 906. doi:10.1002/phar.1788